Integer to Be Acquired by KKR in $5.7 Billion Deal
Plano, Texas & New York – August 3, 2026 Integer Holdings Corporation, one of the world’s largest medical device...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Plano, Texas & New York – August 3, 2026 Integer Holdings Corporation, one of the world’s largest medical device...
STAMFORD, Connecticut, June 30, 2026 Gainline Capital Partners has announced that its portfolio company M&M International, a leading manufacturer...
Louvain-La-Neuve, Belgium, December 19, 2025 — IBA (Ion Beam Applications S.A.), a global leader in particle accelerator technology and...
